Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.
Nat Commun. 2023 Jan 18;14(1):292. doi: 10.1038/s41467-023-35796-7.
Nat Commun. 2023.
PMID: 36653361
Free PMC article.
Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond.
Weitz JR, Tiriac H, Hurtado de Mendoza T, Wascher A, Lowy AM.
Weitz JR, et al. Among authors: wascher a.
Cancers (Basel). 2021 Oct 5;13(19):4991. doi: 10.3390/cancers13194991.
Cancers (Basel). 2021.
PMID: 34638476
Free PMC article.
Review.
Item in Clipboard
A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer.
Cazes A, Betancourt O, Esparza E, Mose ES, Jaquish D, Wong E, Wascher AA, Tiriac H, Gymnopoulos M, Lowy AM.
Cazes A, et al. Among authors: wascher aa.
Clin Cancer Res. 2021 Apr 1;27(7):2100-2110. doi: 10.1158/1078-0432.CCR-20-3210. Epub 2021 Jan 15.
Clin Cancer Res. 2021.
PMID: 33451980
Item in Clipboard
Cite
Cite